Targeted gene delivery to the nervous system using herpes simplex virus vectors

Area of Science:

• Neuroscience
• Gene Therapy
• Molecular Biology

Background:

• Neurotrophic factors show therapeutic potential in vitro and in animal models but face challenges in human application.
• Systemic side effects and the short half-life of peptides limit their clinical use.
• Developing targeted delivery systems is crucial for harnessing the benefits of neurotrophic factors and peptides.

Purpose of the Study:

• To develop a novel gene delivery system using recombinant herpes simplex virus (HSV)-based vectors.
• To investigate the potential of HSV vectors for delivering neurotrophic factor genes to dorsal root ganglion neurons.
• To evaluate the efficacy of HSV vectors in protecting against neuropathy and mediating localized antinociception in animal models.

Main Methods:

• Construction and utilization of recombinant herpes simplex virus (HSV)-based vectors.
• Delivery and expression of neurotrophic factor genes in dorsal root ganglion neurons.
• Administration of vectors expressing proenkephalin for localized antinociceptive effects.

Main Results:

• HSV-based vectors successfully delivered and expressed neurotrophic factor genes in animal models, preventing neuropathy without systemic side effects.
• A vector expressing proenkephalin induced localized antinociception by mediating opioid peptide release.
• Targeted gene delivery via HSV vectors demonstrated the feasibility of using short-lived peptides for specific neurological effects.

Conclusions:

• Recombinant HSV-based vectors provide a viable platform for targeted gene delivery in the nervous system.
• This approach enables the therapeutic application of neurotrophic factors and peptides for neurological conditions.
• HSV-mediated gene therapy offers a promising strategy for treating neuropathy and pain with localized effects.